Literature DB >> 15292266

Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.

Kashelle Lockman1, Jeremiah S Hinson, Matt D Medlin, Dionne Morris, Joan M Taylor, Christopher P Mack.   

Abstract

Sphingosine 1-phosphate (S1P) is a lipid agonist that regulates smooth muscle cell (SMC) and endothelial cell functions by activating several members of the S1P subfamily of G-protein-coupled Edg receptors. We have shown previously that SMC differentiation is regulated by RhoA-dependent activation of serum response factor (SRF). Because S1P is a strong activator of RhoA, we hypothesized that S1P would stimulate SMC differentiation. Treatment of primary rat aortic SMC cells with S1P activated RhoA as measured by precipitation with a glutathione S-transferase-rhotekin fusion protein. In SMC and 10T1/2 cells, S1P treatment up-regulated the activities of several transiently transfected SMC-specific promoters, and these effects were inhibited by the Rho-kinase inhibitor, Y-27632. S1P also increased smooth muscle alpha-actin protein levels in SMC but had no effect on SRF binding to the smooth muscle alpha-actin CArG B element. Quantitative reverse transcriptase-PCR showed that S1P treatment of SMC or 10T1/2 cells did not increase the mRNA level of either of the recently identified SRF co-factors, myocardin or myocardin-related transcription factor-A (MRTF-A). MRTF-A protein was expressed highly in SMC and 10T1/2 cultures, and importantly the effects of S1P were inhibited by a dominant negative form of MRTF-A indicating that S1P may regulate the transcriptional activity of MRTF-A. Indeed, S1P treatment increased the nuclear localization of FLAG-MRTF-A, and the effect of MRTF-A overexpression on smooth muscle alpha-actin promoter activity was inhibited by dominant negative RhoA. S1P also stimulated SMC growth by activating the early growth response gene, c-fos. This effect was not attenuated by Y-27632 but could be inhibited by the MEK inhibitor, UO126. S1P enhanced SMC growth through ERK-mediated phosphorylation of the SRF co-factor, Elk-1, as measured by gel shift and Elk-1 activation assays. Taken together these results demonstrate that S1P activates multiple signaling pathways in SMC and regulates proliferation by ERK-dependent activation of Elk-1 and differentiation by RhoA-dependent activation of MRTF-A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292266     DOI: 10.1074/jbc.M405432200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.

Authors:  Abel Martin-Garrido; David I Brown; Alicia N Lyle; Anna Dikalova; Bonnie Seidel-Rogol; Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2010-11-11       Impact factor: 7.376

2.  Sphingosine-1-phosphate receptor 3 promotes neointimal hyperplasia in mouse iliac-femoral arteries.

Authors:  Takuya Shimizu; Allison De Wispelaere; Martin Winkler; Travis D'Souza; Jacob Caylor; Lihua Chen; Frank Dastvan; Jessie Deou; Aesim Cho; Axel Larena-Avellaneda; Michael Reidy; Guenter Daum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-02       Impact factor: 8.311

3.  Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Anthony O Awojoodu; Soo J Shin; Feilim Mac Gabhann; Timothy L MacDonald; Brian R Wamhoff; Kevin R Lynch; Shayn M Peirce; Edward A Botchwey
Journal:  Tissue Eng Part A       Date:  2010-11-09       Impact factor: 3.845

4.  Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive Remodeling.

Authors:  Peter J Mack; Yuzhi Zhang; Seok Chung; Vernella Vickerman; Roger D Kamm; Guillermo García-Cardeña
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

5.  Engineering vascularized tissues using natural and synthetic small molecules.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Edward A Botchwey
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

6.  Inhibition of Diaphanous Formin Signaling In Vivo Impairs Cardiovascular Development and Alters Smooth Muscle Cell Phenotype.

Authors:  Laura Weise-Cross; Joan M Taylor; Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-17       Impact factor: 8.311

7.  Phosphorylation of myocardin by extracellular signal-regulated kinase.

Authors:  Sebastien Taurin; Nathan Sandbo; Douglas M Yau; Nan Sethakorn; Jacob Kach; Nickolai O Dulin
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

8.  PKA-dependent phosphorylation of serum response factor inhibits smooth muscle-specific gene expression.

Authors:  Alicia L Blaker; Joan M Taylor; Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-24       Impact factor: 8.311

9.  Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury.

Authors:  Allison D Grabski; Takuya Shimizu; Jessie Deou; William M Mahoney; Michael A Reidy; Guenter Daum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

10.  Elevated globotriaosylsphingosine is a hallmark of Fabry disease.

Authors:  Johannes M Aerts; Johanna E Groener; Sijmen Kuiper; Wilma E Donker-Koopman; Anneke Strijland; Roelof Ottenhoff; Cindy van Roomen; Mina Mirzaian; Frits A Wijburg; Gabor E Linthorst; Anouk C Vedder; Saskia M Rombach; Josanne Cox-Brinkman; Pentti Somerharju; Rolf G Boot; Carla E Hollak; Roscoe O Brady; Ben J Poorthuis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.